ucsf logo

Megan Richie, MD

Neurohospitalist • Neurology
General Neurology Parnassus
415-353-2273
Portrait of Megan Richie
Portrait of Megan Richie
ucsf logo

Megan Richie, MD

Neurohospitalist • Neurology
General Neurology Parnassus
415-353-2273

On this page

About me

Dr. Megan Richie is a neurohospitalist, a specialist in caring for hospitalized patients with neurological disorders. Her expertise includes managing strokes, seizures, meningitis, Guillain-Barre syndrome, multiple sclerosis and delirium, as well as less common neurological conditions, such as transverse myelitis (inflammation in a section of the spinal cord), status epilepticus (seizures lasting more than five minutes), infectious encephalitis and autoimmune encephalitis.

Richie earned her medical degree from the Perelman School of Medicine at the University of Pennsylvania, where she also completed a residency in neurology. She completed a neurohospitalist fellowship at UCSF. She is deeply involved in medical education, and serves as director of the neurology clerkship for medical students and director of the master clinician flexible residency program for neurology residents.

Education & training

Board certification

  • Neurology, American Board of Psychiatry and Neurology

Fellowship

  • UCSF Graduate Medical Education

Residency

  • Neurology, Hospital of the University of Pennsylvania

Internship

  • Internal Medicine, Hospital of the University of Pennsylvania

Degree

  • MD, University of Pennsylvania School of Medicine

My expertise

Locations

    My research

    Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

    For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.